The Probable Suspect in the Prediction of Relapse in Acute Leukemia: Thrombocytopenia

İpek Dokurel Çetin, N. Özdemir, T. Celkan, Sarper Erdogan, H. Apak
{"title":"The Probable Suspect in the Prediction of Relapse in Acute Leukemia: Thrombocytopenia","authors":"İpek Dokurel Çetin, N. Özdemir, T. Celkan, Sarper Erdogan, H. Apak","doi":"10.5505/vtd.2022.17092","DOIUrl":null,"url":null,"abstract":"Objective: Relapse is not common in patients with acute leukemia in childhood, however it is a serious complication with high mortality rate . We aimed to predict relapse among pediatric acute leukemia patients in remission by using complete blood parameters which are used routinely in clinical practice. Materials and Methods : The data of 279 children diagnosed with acute leukemia in our clinic over a 20-year period were retrospectively reviewed. Fourty two children relapsed and 37 children non-relapsed acute leukemia cases, all of whose data were available, were included in the study. Blood count parameters and physical examination findings at the time of diagnosis and during the follow-up were evaluated retrospectively in all patients. Mann-Whitney U and T-test were used for comparison of numerical variables. Chi-square test was used to compare categorical variables. Results: In the relapse group; twenty-four children were diagnosed with B-cell ALL, 10 children with T-cell ALL, and eight children with AML. In non-relapse group; 26 children had B-cell ALL, 10 children were diagnosed with T-cell and one child had AML. Thrombocytopenia was observed in 24 patients for the relapse group, compared to nine children in non-relapse group. After remission, the risk of relapse was significantly higher in patients with thrombocytopenia than in patients without thrombocytopenia among both groups. During the remission period, relapse was observed in all patients with thrombocytopenia lasting for an average of 3.86 weeks. Conclusion: Thrombocytopenia during the remission period of pediatric acute leukemia patients can be explained primarily by the effect of chemotherapeutic drugs used in treatment and possible infections on the bone marrow. We demonstrated that the presence of thrombocytopenia which develops after the remission period and lasts longer than three weeks can be used as an easy-to-access blood parameter in the prediction of relapse.","PeriodicalId":23509,"journal":{"name":"Van Medical Journal","volume":"92 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Van Medical Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5505/vtd.2022.17092","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: Relapse is not common in patients with acute leukemia in childhood, however it is a serious complication with high mortality rate . We aimed to predict relapse among pediatric acute leukemia patients in remission by using complete blood parameters which are used routinely in clinical practice. Materials and Methods : The data of 279 children diagnosed with acute leukemia in our clinic over a 20-year period were retrospectively reviewed. Fourty two children relapsed and 37 children non-relapsed acute leukemia cases, all of whose data were available, were included in the study. Blood count parameters and physical examination findings at the time of diagnosis and during the follow-up were evaluated retrospectively in all patients. Mann-Whitney U and T-test were used for comparison of numerical variables. Chi-square test was used to compare categorical variables. Results: In the relapse group; twenty-four children were diagnosed with B-cell ALL, 10 children with T-cell ALL, and eight children with AML. In non-relapse group; 26 children had B-cell ALL, 10 children were diagnosed with T-cell and one child had AML. Thrombocytopenia was observed in 24 patients for the relapse group, compared to nine children in non-relapse group. After remission, the risk of relapse was significantly higher in patients with thrombocytopenia than in patients without thrombocytopenia among both groups. During the remission period, relapse was observed in all patients with thrombocytopenia lasting for an average of 3.86 weeks. Conclusion: Thrombocytopenia during the remission period of pediatric acute leukemia patients can be explained primarily by the effect of chemotherapeutic drugs used in treatment and possible infections on the bone marrow. We demonstrated that the presence of thrombocytopenia which develops after the remission period and lasts longer than three weeks can be used as an easy-to-access blood parameter in the prediction of relapse.
预测急性白血病复发的可能因素:血小板减少症
目的:儿童期急性白血病的复发并不常见,但它是一种严重的并发症,死亡率高。我们的目的是通过使用临床常规使用的全血参数来预测缓解期儿科急性白血病患者的复发。材料与方法:回顾性分析我院近20年来279例急性白血病患儿的资料。42例复发儿童和37例非复发儿童急性白血病病例纳入研究,所有数据均可获得。对所有患者在诊断时和随访期间的血细胞计数参数和体格检查结果进行回顾性评估。数值变量比较采用Mann-Whitney U检验和t检验。分类变量比较采用卡方检验。结果:复发组;24名儿童被诊断为b细胞ALL, 10名儿童被诊断为t细胞ALL, 8名儿童被诊断为急性髓性白血病。非复发组;26名儿童患有b细胞性ALL, 10名儿童被诊断为t细胞,1名儿童患有急性髓性白血病。复发组有24例患者出现血小板减少,而非复发组只有9例。缓解后,两组中有血小板减少的患者复发的风险明显高于无血小板减少的患者。在缓解期,所有血小板减少患者的复发平均持续3.86周。结论:小儿急性白血病缓解期血小板减少主要与化疗药物的疗效及可能的骨髓感染有关。我们证明,在缓解期后出现的血小板减少症持续时间超过三周,可以作为预测复发的一个容易获得的血液参数。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信